Stock BTSG BRIGHTSPRING HEALTH SERVICES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus BrightSpring Health Services, Inc.

Equities

BTSG

US10950A1060

Market Closed - Nasdaq
Other stock markets
 21:00:00 24/05/2024 BST 		5-day change 1st Jan Change
11.32 USD -0.96% Intraday chart for BrightSpring Health Services, Inc. -0.70% 0.00%
05-22 BrightSpring Health Services Completes Three Acquisitions MT
05-20 BrightSpring Health Services Says Onco360 Selected as Pharmacy Partner for Ojemda MT

Evolution of the average Target Price on BrightSpring Health Services, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e8a2b5644cc8.qzhO8tzfXepn7b3N_h3oVhLeEzwxyBbYQC71zzY0s4A.wmcalL-XbqYgpfCmrFqeAyGYVhEGqVOPBWS4iE5exbWYWj-FhZMNqBWV0g~68300b34bf4b0cfc57eeb7d03e4af964

Analyst Recommendations on BrightSpring Health Services, Inc.

Wells Fargo Adjusts Price Target on BrightSpring Health Services to $16 From $15, Maintains Overweight Rating MT
Deutsche Bank Adjusts BrightSpring Health Services Price Target to $13 From $11.50, Maintains Buy Rating MT
BrightSpring Health Services Insider Bought Shares Worth $297,712, According to a Recent SEC Filing MT
HSBC Starts Coverage on BrightSpring Health With Buy Rating, $13 Price Target MT
Goldman Sachs Cuts Price Target on BrightSpring Health to $23 From $26, Maintains Buy Rating MT
Deutsche Bank Upgrades BrightSpring Health Services to Buy From Hold, $11.50 Price Target MT
Leerink Partners Starts BrightSpring Health Services With Outperform Rating, $15 Price Target MT
BofA Securities Starts BrightSpring Health Services With Buy Rating, $14 Price Target MT
UBS Initiates Brightspring Health Services at Buy Rating With $15 Price Target MT
Morgan Stanley Initiates Brightspring Health Services at Overweight Rating With $18 Price Target MT
Goldman Sachs Starts Coverage on BrightSpring Health With Buy Rating, $26 Price Target MT
Wells Fargo Initiates Brightspring Health Services at Overweight Rating With $15 Price Target MT
Jefferies Initiates Brightspring Health Services at Buy Rating With $18 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
11.32 USD
Average target price
16.23 USD
Spread / Average Target
+43.35%
High Price Target
23 USD
Spread / Highest target
+103.18%
Low Price Target
13 USD
Spread / Lowest Target
+14.84%

Consensus detail

Consensus revision (last 18 months)

Analysts covering BrightSpring Health Services, Inc.

Wells Fargo Securities
Deutsche Bank Securities
HSBC
Goldman Sachs
BofA Securities
Leerink Partners
UBS
Jefferies & Co.
Morgan Stanley

Ratings for BrightSpring Health Services, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BTSG Stock
  4. Consensus BrightSpring Health Services, Inc.